CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
CytoFab aims to revolutionize personalized medicine by creating an automated platform for large-scale production of patient-specific human cells. This modular system integrates advanced technologies to enhance efficiency, quality, and adaptability in cell manufacturing, enabling broader applications in regenerative the…
Personalized medicine (e.g. regenerative, such as cell therapy or patient-specific tested and composed pharmaceuticals) has huge potential.
But to exploit this potential, it is necessary to produce human cells patient-specific in industrial scale.
Nowadays, personalized cell production is only executed by means of manual processing on laboratory scale.
In Order to make patient-specific production of cells available for a wide range of applications, CytoFab focuses on the development of an intell…
FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Switzerland, Gals
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Finland, Abo
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, SCHERIN
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Finland, Tampere
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
